Still sees 2024 revenue $130M-$142M vs. $131.3M in 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VKTX:
- Viking Therapeutics call volume above normal and directionally bullish
- Viking Therapeutics rumor highlighted again by Betaville blog
- Viking Therapeutics price target raised to $35 from $30 at Stifel
- Viking Therapeutics price target raised to $38 from $32 at Truist
- Viking Therapeutics management to meet virtually with Oppenheimer